Skip to main content
. 2011 May 31;10:7. doi: 10.1186/1477-5751-10-7

Figure 5.

Figure 5

Proportions of tumors in the three trial cohorts for which there was 4/5 or 5/5 agreement on grade among five pathologists during phase 1 of the study.